rabbit anti p cdcp1 y734 (Cell Signaling Technology Inc)

Cell Signaling Technology Inc is a verified supplier

Cell Signaling Technology Inc manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Cell Signaling Technology Inc rabbit anti p cdcp1 y734

Antibody-induced loss of <t>CDCP1</t> from the cell surface. ( A ) Western blot analysis of lysates from the indicated cell lines using two mouse monoclonal anti-CDCP1 antibodies, 10D7 and 41-2 (1 µg/ml), a commercial rabbit polyclonal anti-CDCP1 antibody, 4115 (1:2,000 dilution), and an anti-GAPDH antibody (1:10,000). ( B ) Flow cytometry analysis of the indicated cell lines for plasma membrane localized CDCP1 using 10D7 and 41-2. Fixed cells were stained with the respective anti-CDCP1 antibody followed by an APC-conjugated anti-mouse IgG, then analysed by flow cytometry. Data are displayed graphically as MFI values corrected for background signal determined from cells stained with only the APC-conjugated anti-mouse IgG. 10D7 and 41-2 identified the same proportion of CDCP1 expressing cells as: HEY 89%; CAOV3 93%; SKOV3 99%; OVTOKO 86%; OVZM6 0%; OVMZ6-CDCP1 75%. ( C, D ) Flow cytometry analysis of HEY (c) and OVMZ6-CDCP1 (d) cells treated for 30 minutes at 37°C with 10D7, 41-2 or control IgG 1 κ (5µg/ml). Treated cells were fixed and plasma membrane localized CDCP1 detected using fluorescently tagged anti-CDCP1 antibody CD318 -PE . Background signal was assessed by staining treated cells with fluorescently tagged control IgG (IgG -PE ). Data are displayed as MFI values. All data are mean ± SEM from three independent experiments. ***P<0.001.

Rabbit Anti P Cdcp1 Y734, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti p cdcp1 y734/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
Price from $9.99 to $1999.99

rabbit anti p cdcp1 y734 - by Bioz Stars, 2023-04

93/100 stars

Images

1) Product Images from "Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer"

Article Title: Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer

Journal: Theranostics

doi: 10.7150/thno.30736

Antibody-induced loss of CDCP1 from the cell surface. ( A ) Western blot analysis of lysates from the indicated cell lines using two mouse monoclonal anti-CDCP1 antibodies, 10D7 and 41-2 (1 µg/ml), a commercial rabbit polyclonal anti-CDCP1 antibody, 4115 (1:2,000 dilution), and an anti-GAPDH antibody (1:10,000). ( B ) Flow cytometry analysis of the indicated cell lines for plasma membrane localized CDCP1 using 10D7 and 41-2. Fixed cells were stained with the respective anti-CDCP1 antibody followed by an APC-conjugated anti-mouse IgG, then analysed by flow cytometry. Data are displayed graphically as MFI values corrected for background signal determined from cells stained with only the APC-conjugated anti-mouse IgG. 10D7 and 41-2 identified the same proportion of CDCP1 expressing cells as: HEY 89%; CAOV3 93%; SKOV3 99%; OVTOKO 86%; OVZM6 0%; OVMZ6-CDCP1 75%. ( C, D ) Flow cytometry analysis of HEY (c) and OVMZ6-CDCP1 (d) cells treated for 30 minutes at 37°C with 10D7, 41-2 or control IgG 1 κ (5µg/ml). Treated cells were fixed and plasma membrane localized CDCP1 detected using fluorescently tagged anti-CDCP1 antibody CD318 -PE . Background signal was assessed by staining treated cells with fluorescently tagged control IgG (IgG -PE ). Data are displayed as MFI values. All data are mean ± SEM from three independent experiments. ***P<0.001.

Figure Legend Snippet: Antibody-induced loss of CDCP1 from the cell surface. ( A ) Western blot analysis of lysates from the indicated cell lines using two mouse monoclonal anti-CDCP1 antibodies, 10D7 and 41-2 (1 µg/ml), a commercial rabbit polyclonal anti-CDCP1 antibody, 4115 (1:2,000 dilution), and an anti-GAPDH antibody (1:10,000). ( B ) Flow cytometry analysis of the indicated cell lines for plasma membrane localized CDCP1 using 10D7 and 41-2. Fixed cells were stained with the respective anti-CDCP1 antibody followed by an APC-conjugated anti-mouse IgG, then analysed by flow cytometry. Data are displayed graphically as MFI values corrected for background signal determined from cells stained with only the APC-conjugated anti-mouse IgG. 10D7 and 41-2 identified the same proportion of CDCP1 expressing cells as: HEY 89%; CAOV3 93%; SKOV3 99%; OVTOKO 86%; OVZM6 0%; OVMZ6-CDCP1 75%. ( C, D ) Flow cytometry analysis of HEY (c) and OVMZ6-CDCP1 (d) cells treated for 30 minutes at 37°C with 10D7, 41-2 or control IgG 1 κ (5µg/ml). Treated cells were fixed and plasma membrane localized CDCP1 detected using fluorescently tagged anti-CDCP1 antibody CD318 -PE . Background signal was assessed by staining treated cells with fluorescently tagged control IgG (IgG -PE ). Data are displayed as MFI values. All data are mean ± SEM from three independent experiments. ***P<0.001.

Techniques Used: Western Blot, Flow Cytometry, Staining, Expressing

Degradation of CDCP1 induced by internalizing mAbs 41-2 and 10D7. ( A ) Western blot analysis, using anti-CDCP1 antibody 4115 (1:2,000) and an anti-GAPDH antibody (1:10,000), of lysates from HEY cells treated with isotype matched control IgG ( lef t), 10D7 (middle) or 41-2 (right) for the indicated times. ( B ) Graph of fluorescence versus time from HeLa and HeLa-CDCP1 cells treated with 10D7 pH (5µg/ml) ( left ), and graph of fluorescence signal from six EOC cell lines following treatment with 10D7 pH or 41-2 pH (5µg/ml) for 8 hours ( right ). RFU, relative fluorescence units. ( C ) Impact of lysosomal ( left ) and proteasomal ( right ) inhibition on antibody-induced degradation of CDCP1. Top panel , Anti-CDCP1 (1:2,000) and -GAPDH (1:10,000) Western blot analysis of HEY cells treated with 10D7 in the presence or absence of the lysosomal inhibitor chloroquine (CLQ; 50 µM), or the proteasomal inhibitor MG132 (20 µM) for the indicated times. Bottom panel , Graph of the ratio of CDCP1 to GAPDH signal generated from Western blot analyses of lysates from three independent assays assessing the effect of CLQ and MG132 on 10D7-induced degradation of CDCP1. All data represent mean ± SEM from three independent experiments. *P<0.05.

Figure Legend Snippet: Degradation of CDCP1 induced by internalizing mAbs 41-2 and 10D7. ( A ) Western blot analysis, using anti-CDCP1 antibody 4115 (1:2,000) and an anti-GAPDH antibody (1:10,000), of lysates from HEY cells treated with isotype matched control IgG ( lef t), 10D7 (middle) or 41-2 (right) for the indicated times. ( B ) Graph of fluorescence versus time from HeLa and HeLa-CDCP1 cells treated with 10D7 pH (5µg/ml) ( left ), and graph of fluorescence signal from six EOC cell lines following treatment with 10D7 pH or 41-2 pH (5µg/ml) for 8 hours ( right ). RFU, relative fluorescence units. ( C ) Impact of lysosomal ( left ) and proteasomal ( right ) inhibition on antibody-induced degradation of CDCP1. Top panel , Anti-CDCP1 (1:2,000) and -GAPDH (1:10,000) Western blot analysis of HEY cells treated with 10D7 in the presence or absence of the lysosomal inhibitor chloroquine (CLQ; 50 µM), or the proteasomal inhibitor MG132 (20 µM) for the indicated times. Bottom panel , Graph of the ratio of CDCP1 to GAPDH signal generated from Western blot analyses of lysates from three independent assays assessing the effect of CLQ and MG132 on 10D7-induced degradation of CDCP1. All data represent mean ± SEM from three independent experiments. *P<0.05.

Techniques Used: Western Blot, Fluorescence, Inhibition, Generated

10D7 and 41-2 bind with high affinity to the ECD of CDCP1. ( A ) Schematic representation of full length CDCP1 (CDCP1 FL ) and progressively shorter carboxyl terminal truncations (CDCP1-T358, -S416, -K554, -D665). CUB domains are colored green. ( B ) 10D7 and 41-2 (1 µg/ml) Western blot analysis of conditioned media from OVMZ6 cells transiently transfected with a control vector of constructs encoding CDCP1-T358, -S416, -K554, or -D665. ( C ) Flow cytometry analysis of HEY cells incubated with: (i) 10D7-QDot 625 for 1 h, unlabelled 41-2 for 1 h then 10D7-QDot 625 for 1 h, or concurrently with 10D7-QDot 625 and 41-2 for 1 h; or (ii) CD318 -PE for 1 h, unlabelled 10D7 or 41-2 for 1 h then CD318 -PE for 1 h, or concurrently with 10D7 or 41-2 and CD318 -PE for 1 h. ( D ) Schematic of CDCP1 showing the regions to which antibodies 10D7, 41-2, CD318 and 4115 bind. ( E ) Top panels , Sensorgrams of CDCP1-ECD (concentration range 1.56 to 50 nM) binding to immobilized 10D7 (left) and 41-2 (right) depicting association (increasing signal) and dissociation (reducing signal) over time. Bottom panel , Table of kinetic parameters. k a , association rate; k d , dissociation rate; K D , affinity constant.

Figure Legend Snippet: 10D7 and 41-2 bind with high affinity to the ECD of CDCP1. ( A ) Schematic representation of full length CDCP1 (CDCP1 FL ) and progressively shorter carboxyl terminal truncations (CDCP1-T358, -S416, -K554, -D665). CUB domains are colored green. ( B ) 10D7 and 41-2 (1 µg/ml) Western blot analysis of conditioned media from OVMZ6 cells transiently transfected with a control vector of constructs encoding CDCP1-T358, -S416, -K554, or -D665. ( C ) Flow cytometry analysis of HEY cells incubated with: (i) 10D7-QDot 625 for 1 h, unlabelled 41-2 for 1 h then 10D7-QDot 625 for 1 h, or concurrently with 10D7-QDot 625 and 41-2 for 1 h; or (ii) CD318 -PE for 1 h, unlabelled 10D7 or 41-2 for 1 h then CD318 -PE for 1 h, or concurrently with 10D7 or 41-2 and CD318 -PE for 1 h. ( D ) Schematic of CDCP1 showing the regions to which antibodies 10D7, 41-2, CD318 and 4115 bind. ( E ) Top panels , Sensorgrams of CDCP1-ECD (concentration range 1.56 to 50 nM) binding to immobilized 10D7 (left) and 41-2 (right) depicting association (increasing signal) and dissociation (reducing signal) over time. Bottom panel , Table of kinetic parameters. k a , association rate; k d , dissociation rate; K D , affinity constant.

Techniques Used: Western Blot, Transfection, Plasmid Preparation, Construct, Flow Cytometry, Incubation, Concentration Assay, Binding Assay

10D7-induces cell surface rapid clustering and lysosomal trafficking of CDCP1. ( A ) Live-cell confocal microscopy images of HEY-CDCP1 GFP cells treated with 10D7 pH (5µg/ ml). Internalization of CDCP1 GFP and 10D7 pH was observed at 1 frame per second for 600 s. Insets highlight green punctate CDCP1 GFP positive cellular structures at 30 s, and white cellular structures at 600s that are positive for both CDCP1 GFP and 10D7 pH . ( B ) Graph of complex formation between IgG pH and CDCP1 GFP determined as the percentage of IgG pH signal coincident with CDCP1 GFP signal using ImageJ software analysis. ( C ) Images of the plasma membrane and proximal cytoplasmic region of HEY-CDCP1 GFP cells indicating 10D7-induced clustering of CDCP1. In untreated cells CDCP1 GFP is located diffusely on the cell surface. In treated cells, arrowheads highlight rapid 10D7-induced clustering of CDCP1 GFP and its internalization. ( D ) Left panel , Overlay of CDCP1 GFP (green) and 10D7 pH (magenta) signals in HEY-CDCP1 GFP cells after 20 minutes of treatment showing co-localization of within endosomal-like structures. Middle panel , Black and white image of CDCP1 GFP signal. Right panel , Black and white image of 10D7 pH signal. ( E ) Live-cell confocal microscopy images of HEY-CDCP1 GFP cells treated with IgG7 pH (5µg/ ml). No internalization of CDCP1 GFP was observed within 300 s of treatment with IgG7 pH .

Figure Legend Snippet: 10D7-induces cell surface rapid clustering and lysosomal trafficking of CDCP1. ( A ) Live-cell confocal microscopy images of HEY-CDCP1 GFP cells treated with 10D7 pH (5µg/ ml). Internalization of CDCP1 GFP and 10D7 pH was observed at 1 frame per second for 600 s. Insets highlight green punctate CDCP1 GFP positive cellular structures at 30 s, and white cellular structures at 600s that are positive for both CDCP1 GFP and 10D7 pH . ( B ) Graph of complex formation between IgG pH and CDCP1 GFP determined as the percentage of IgG pH signal coincident with CDCP1 GFP signal using ImageJ software analysis. ( C ) Images of the plasma membrane and proximal cytoplasmic region of HEY-CDCP1 GFP cells indicating 10D7-induced clustering of CDCP1. In untreated cells CDCP1 GFP is located diffusely on the cell surface. In treated cells, arrowheads highlight rapid 10D7-induced clustering of CDCP1 GFP and its internalization. ( D ) Left panel , Overlay of CDCP1 GFP (green) and 10D7 pH (magenta) signals in HEY-CDCP1 GFP cells after 20 minutes of treatment showing co-localization of within endosomal-like structures. Middle panel , Black and white image of CDCP1 GFP signal. Right panel , Black and white image of 10D7 pH signal. ( E ) Live-cell confocal microscopy images of HEY-CDCP1 GFP cells treated with IgG7 pH (5µg/ ml). No internalization of CDCP1 GFP was observed within 300 s of treatment with IgG7 pH .

Techniques Used: Confocal Microscopy, Software

$CDCP1 is tyrosine phosphorylated during 10D7-induced internalization and degradation. ( A ) Lysates from HEY cells treated with 10D7 (5µg/ml) for the indicated times were examined by Western blot analysis for CDCP1, p-CDCP1-Y734, Src, p-Src-Y416, and GAPDH. Antibody dilution was 1:2,000 except the anti-GAPDH antibody which was 1:10,000. The graphs display CDCP1 and p-CDCP1-Y734 levels determined by densitometric analysis with data representing mean ± SEM from three independent experiments. ( B ) Anti-CDCP1 (1:2,000), -GFP (1:2,000) and -GAPDH (1:10,000) Western blot analysis of fractions collected by cell surface biotinylation of HEY cells expressing CDCP1 GFP , CDCP1 GFP -Y734F, -Y743F or -Y762F. ( C ) Analysis of semi-automated computer tracking of CDCP1 GFP and CDCP1 GFP -Y734F, -Y743F and -Y762F in response to 10D7. Left , representative image of CDCP1 GFP tracks that internalized in response to 10D7 pH in HEY cells. The image is an overlay onto cells of color-coded tracks (violet, tracks that moved the shortest distance; red, the tracks that moved the greatest distance). Right , Graph of distance moved over 5 min by CDCP1 GFP and CDCP1 GFP -Y734F, -Y743F and -Y762F in response to 10D7 (5 µg/ml). Data are median and range from the 100 tracks with the highest velocity in each experimental group from three independent experiments. ***P<0.001.$
Figure Legend Snippet: CDCP1 is tyrosine phosphorylated during 10D7-induced internalization and degradation. ( A ) Lysates from HEY cells treated with 10D7 (5µg/ml) for the indicated times were examined by Western blot analysis for CDCP1, p-CDCP1-Y734, Src, p-Src-Y416, and GAPDH. Antibody dilution was 1:2,000 except the anti-GAPDH antibody which was 1:10,000. The graphs display CDCP1 and p-CDCP1-Y734 levels determined by densitometric analysis with data representing mean ± SEM from three independent experiments. ( B ) Anti-CDCP1 (1:2,000), -GFP (1:2,000) and -GAPDH (1:10,000) Western blot analysis of fractions collected by cell surface biotinylation of HEY cells expressing CDCP1 GFP , CDCP1 GFP -Y734F, -Y743F or -Y762F. ( C ) Analysis of semi-automated computer tracking of CDCP1 GFP and CDCP1 GFP -Y734F, -Y743F and -Y762F in response to 10D7. Left , representative image of CDCP1 GFP tracks that internalized in response to 10D7 pH in HEY cells. The image is an overlay onto cells of color-coded tracks (violet, tracks that moved the shortest distance; red, the tracks that moved the greatest distance). Right , Graph of distance moved over 5 min by CDCP1 GFP and CDCP1 GFP -Y734F, -Y743F and -Y762F in response to 10D7 (5 µg/ml). Data are median and range from the 100 tracks with the highest velocity in each experimental group from three independent experiments. ***P<0.001.

Techniques Used: Western Blot, Expressing

The Src inhibitor dasatinib blocks 10D7-induced phosphorylation and internalization of CDCP1. ( A ) HEY cells, treated for 2 h with dasatinib (200 nM), were incubated with 10D7 (5µg/ ml) for the indicated times. Lysates were examined by Western blot analysis for CDCP1 (1:2,000), pCDCP1-Y734 (1:2,000) and GAPDH (1:10,000). ( B ) Live-cell confocal microscopy images, acquired at the indicated time points after antibody treatment, of HEY-CDCP1 GFP cells pre-treated with dasatinib (200 nM), then incubated with 10D7 pH . Lower panels , 10D7 pH signal. Middle panels , CDCP1 GFP signal. Upper panels , overlay of 10D7 pH and CDCP1 GFP signals. ( C ) Graph of distance moved over 5 min by CDCP1 GFP in response to 10D7 in the presence and absence of dasatinib. Data are median and range from the 100 tracks with the highest velocity in each experimental group from three independent experiments. ***P<0.001.

Figure Legend Snippet: The Src inhibitor dasatinib blocks 10D7-induced phosphorylation and internalization of CDCP1. ( A ) HEY cells, treated for 2 h with dasatinib (200 nM), were incubated with 10D7 (5µg/ ml) for the indicated times. Lysates were examined by Western blot analysis for CDCP1 (1:2,000), pCDCP1-Y734 (1:2,000) and GAPDH (1:10,000). ( B ) Live-cell confocal microscopy images, acquired at the indicated time points after antibody treatment, of HEY-CDCP1 GFP cells pre-treated with dasatinib (200 nM), then incubated with 10D7 pH . Lower panels , 10D7 pH signal. Middle panels , CDCP1 GFP signal. Upper panels , overlay of 10D7 pH and CDCP1 GFP signals. ( C ) Graph of distance moved over 5 min by CDCP1 GFP in response to 10D7 in the presence and absence of dasatinib. Data are median and range from the 100 tracks with the highest velocity in each experimental group from three independent experiments. ***P<0.001.

Techniques Used: Incubation, Western Blot, Confocal Microscopy

PET-CT imaging of an EOC PDX. ( A ) Clear cell EOC PDX PH250. Left , hematoxylin and eosin stained section highlighting clear cell features at 40X with 10X magnification (inset). Right , Anti-CDCP1 immunohistochemistry (antibody 4115) highlighting strong CDCP1 expression by malignant cells with accentuation of signal on the plasma membrane at 40X and 10X magnification (inset). ( B ) Comparison of CDCP1 expression by HEY cells and PDX PH250 cells. Left , Anti-CDCP1 (antibody 4115; 1:2,000) and GAPDH (1:10,000) Western blot analysis of lysates from HEY cells, a HEY cell xenograft, and a PH250 PDX tumor. Right , Cell surface CDCP1 receptor number determined by flow cytometry of single cell suspensions of HEY cells and PDX PH250 cells. Receptor numbers per cell are indicated above the flow cytometry peaks. ( C ) Representative PET images of mice carrying subcutaneous PH250 PDX tumors on both flanks. 89 Zr-10D7 and 89 Zr-IgG1κ were injected intravenously three weeks after tumor cell inoculation, and imaging performed 144 h later. White arrowhead, tumor nodules. Yellow arrow, 89 Zr-IgG1κ signal accumulated in the spleen. ( D ) Quantitative bio-distribution analysis of 89 Zr-10D7 and 89 Zr-IgG1κ 144 h post injection (n = 4). 10D7 accumulates in tumors to a significantly higher degree than IgG1κ which accumulates in the spleen and liver. ***, P<0.001.

Figure Legend Snippet: PET-CT imaging of an EOC PDX. ( A ) Clear cell EOC PDX PH250. Left , hematoxylin and eosin stained section highlighting clear cell features at 40X with 10X magnification (inset). Right , Anti-CDCP1 immunohistochemistry (antibody 4115) highlighting strong CDCP1 expression by malignant cells with accentuation of signal on the plasma membrane at 40X and 10X magnification (inset). ( B ) Comparison of CDCP1 expression by HEY cells and PDX PH250 cells. Left , Anti-CDCP1 (antibody 4115; 1:2,000) and GAPDH (1:10,000) Western blot analysis of lysates from HEY cells, a HEY cell xenograft, and a PH250 PDX tumor. Right , Cell surface CDCP1 receptor number determined by flow cytometry of single cell suspensions of HEY cells and PDX PH250 cells. Receptor numbers per cell are indicated above the flow cytometry peaks. ( C ) Representative PET images of mice carrying subcutaneous PH250 PDX tumors on both flanks. 89 Zr-10D7 and 89 Zr-IgG1κ were injected intravenously three weeks after tumor cell inoculation, and imaging performed 144 h later. White arrowhead, tumor nodules. Yellow arrow, 89 Zr-IgG1κ signal accumulated in the spleen. ( D ) Quantitative bio-distribution analysis of 89 Zr-10D7 and 89 Zr-IgG1κ 144 h post injection (n = 4). 10D7 accumulates in tumors to a significantly higher degree than IgG1κ which accumulates in the spleen and liver. ***, P<0.001.

Techniques Used: Positron Emission Tomography-Computed Tomography, Imaging, Staining, Immunohistochemistry, Expressing, Western Blot, Flow Cytometry, Injection

10D7-MMAE selectively inhibits colony formation of CDCP1 expressing but not non-expressing EOC cells. ( A ) Commassie stained gel of IgG and 10D7, and purified products from reactions of IgG and 10D7 with MMAE. ( B ) HEY cells were treated with 10D7-MMAE (5 µg/ml) for the indicated times and lysates examined by Western blot analysis for CDCP1, p-CDCP1-Y734, Src, p-Src-Y416 and GAPDH. Antibody dilution was 1:2,000 except the anti-GAPDH antibody which was 1:10,000. ( C ) Representative images of crystal violet stained colonies formed from HEY and OVMZ6-CDCP1 cells after treatment with the indicated concentrations of IgG, IgG-MMAE, 10D7 or 10D7-MMAE. ( D ) Graph of crystal violet staining, as a percentage of area (% Area), of colonies formed by HEY, OVMZ6-CDCP1 and OVMZ6 cells after treatment with increasing concentrations of IgG, IgG-MMAE, 10D7 or 10D7-MMAE. Data represent means ± SEM from three independent experiments. ***, P<0.001.

Figure Legend Snippet: 10D7-MMAE selectively inhibits colony formation of CDCP1 expressing but not non-expressing EOC cells. ( A ) Commassie stained gel of IgG and 10D7, and purified products from reactions of IgG and 10D7 with MMAE. ( B ) HEY cells were treated with 10D7-MMAE (5 µg/ml) for the indicated times and lysates examined by Western blot analysis for CDCP1, p-CDCP1-Y734, Src, p-Src-Y416 and GAPDH. Antibody dilution was 1:2,000 except the anti-GAPDH antibody which was 1:10,000. ( C ) Representative images of crystal violet stained colonies formed from HEY and OVMZ6-CDCP1 cells after treatment with the indicated concentrations of IgG, IgG-MMAE, 10D7 or 10D7-MMAE. ( D ) Graph of crystal violet staining, as a percentage of area (% Area), of colonies formed by HEY, OVMZ6-CDCP1 and OVMZ6 cells after treatment with increasing concentrations of IgG, IgG-MMAE, 10D7 or 10D7-MMAE. Data represent means ± SEM from three independent experiments. ***, P<0.001.

Techniques Used: Expressing, Staining, Purification, Western Blot

Similar Products

rabbit anti p cdcp1 y734 (Cell Signaling Technology Inc)

Cell Signaling Technology Inc rabbit anti p cdcp1 y734

rabbit anti p cdcp1 y734 - by Bioz Stars, 2023-04

93/100 stars

Buy from Supplier

Image Search Results

Journal: Theranostics

Article Title: Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer

doi: 10.7150/thno.30736

Figure Lengend Snippet: Antibody-induced loss of CDCP1 from the cell surface. ( A ) Western blot analysis of lysates from the indicated cell lines using two mouse monoclonal anti-CDCP1 antibodies, 10D7 and 41-2 (1 µg/ml), a commercial rabbit polyclonal anti-CDCP1 antibody, 4115 (1:2,000 dilution), and an anti-GAPDH antibody (1:10,000). ( B ) Flow cytometry analysis of the indicated cell lines for plasma membrane localized CDCP1 using 10D7 and 41-2. Fixed cells were stained with the respective anti-CDCP1 antibody followed by an APC-conjugated anti-mouse IgG, then analysed by flow cytometry. Data are displayed graphically as MFI values corrected for background signal determined from cells stained with only the APC-conjugated anti-mouse IgG. 10D7 and 41-2 identified the same proportion of CDCP1 expressing cells as: HEY 89%; CAOV3 93%; SKOV3 99%; OVTOKO 86%; OVZM6 0%; OVMZ6-CDCP1 75%. ( C, D ) Flow cytometry analysis of HEY (c) and OVMZ6-CDCP1 (d) cells treated for 30 minutes at 37°C with 10D7, 41-2 or control IgG 1 κ (5µg/ml). Treated cells were fixed and plasma membrane localized CDCP1 detected using fluorescently tagged anti-CDCP1 antibody CD318 -PE . Background signal was assessed by staining treated cells with fluorescently tagged control IgG (IgG -PE ). Data are displayed as MFI values. All data are mean ± SEM from three independent experiments. ***P<0.001.

Article Snippet: Rabbit anti-CDCP1 (#4115), rabbit anti-p-CDCP1-Y734 (#9050), mouse anti-Src (#2110) and rabbit anti-p-Src-Y416 family (#2101) antibodies were from Cell Signaling Technology (Gold Coast, Australia).

Techniques: Western Blot, Flow Cytometry, Staining, Expressing

Journal: Theranostics

Article Title: Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer

doi: 10.7150/thno.30736

Figure Lengend Snippet: Degradation of CDCP1 induced by internalizing mAbs 41-2 and 10D7. ( A ) Western blot analysis, using anti-CDCP1 antibody 4115 (1:2,000) and an anti-GAPDH antibody (1:10,000), of lysates from HEY cells treated with isotype matched control IgG ( lef t), 10D7 (middle) or 41-2 (right) for the indicated times. ( B ) Graph of fluorescence versus time from HeLa and HeLa-CDCP1 cells treated with 10D7 pH (5µg/ml) ( left ), and graph of fluorescence signal from six EOC cell lines following treatment with 10D7 pH or 41-2 pH (5µg/ml) for 8 hours ( right ). RFU, relative fluorescence units. ( C ) Impact of lysosomal ( left ) and proteasomal ( right ) inhibition on antibody-induced degradation of CDCP1. Top panel , Anti-CDCP1 (1:2,000) and -GAPDH (1:10,000) Western blot analysis of HEY cells treated with 10D7 in the presence or absence of the lysosomal inhibitor chloroquine (CLQ; 50 µM), or the proteasomal inhibitor MG132 (20 µM) for the indicated times. Bottom panel , Graph of the ratio of CDCP1 to GAPDH signal generated from Western blot analyses of lysates from three independent assays assessing the effect of CLQ and MG132 on 10D7-induced degradation of CDCP1. All data represent mean ± SEM from three independent experiments. *P<0.05.

Techniques: Western Blot, Fluorescence, Inhibition, Generated

Journal: Theranostics

Article Title: Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer

doi: 10.7150/thno.30736

Figure Lengend Snippet: 10D7 and 41-2 bind with high affinity to the ECD of CDCP1. ( A ) Schematic representation of full length CDCP1 (CDCP1 FL ) and progressively shorter carboxyl terminal truncations (CDCP1-T358, -S416, -K554, -D665). CUB domains are colored green. ( B ) 10D7 and 41-2 (1 µg/ml) Western blot analysis of conditioned media from OVMZ6 cells transiently transfected with a control vector of constructs encoding CDCP1-T358, -S416, -K554, or -D665. ( C ) Flow cytometry analysis of HEY cells incubated with: (i) 10D7-QDot 625 for 1 h, unlabelled 41-2 for 1 h then 10D7-QDot 625 for 1 h, or concurrently with 10D7-QDot 625 and 41-2 for 1 h; or (ii) CD318 -PE for 1 h, unlabelled 10D7 or 41-2 for 1 h then CD318 -PE for 1 h, or concurrently with 10D7 or 41-2 and CD318 -PE for 1 h. ( D ) Schematic of CDCP1 showing the regions to which antibodies 10D7, 41-2, CD318 and 4115 bind. ( E ) Top panels , Sensorgrams of CDCP1-ECD (concentration range 1.56 to 50 nM) binding to immobilized 10D7 (left) and 41-2 (right) depicting association (increasing signal) and dissociation (reducing signal) over time. Bottom panel , Table of kinetic parameters. k a , association rate; k d , dissociation rate; K D , affinity constant.

Techniques: Western Blot, Transfection, Plasmid Preparation, Construct, Flow Cytometry, Incubation, Concentration Assay, Binding Assay

Journal: Theranostics

Article Title: Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer

doi: 10.7150/thno.30736

Figure Lengend Snippet: 10D7-induces cell surface rapid clustering and lysosomal trafficking of CDCP1. ( A ) Live-cell confocal microscopy images of HEY-CDCP1 GFP cells treated with 10D7 pH (5µg/ ml). Internalization of CDCP1 GFP and 10D7 pH was observed at 1 frame per second for 600 s. Insets highlight green punctate CDCP1 GFP positive cellular structures at 30 s, and white cellular structures at 600s that are positive for both CDCP1 GFP and 10D7 pH . ( B ) Graph of complex formation between IgG pH and CDCP1 GFP determined as the percentage of IgG pH signal coincident with CDCP1 GFP signal using ImageJ software analysis. ( C ) Images of the plasma membrane and proximal cytoplasmic region of HEY-CDCP1 GFP cells indicating 10D7-induced clustering of CDCP1. In untreated cells CDCP1 GFP is located diffusely on the cell surface. In treated cells, arrowheads highlight rapid 10D7-induced clustering of CDCP1 GFP and its internalization. ( D ) Left panel , Overlay of CDCP1 GFP (green) and 10D7 pH (magenta) signals in HEY-CDCP1 GFP cells after 20 minutes of treatment showing co-localization of within endosomal-like structures. Middle panel , Black and white image of CDCP1 GFP signal. Right panel , Black and white image of 10D7 pH signal. ( E ) Live-cell confocal microscopy images of HEY-CDCP1 GFP cells treated with IgG7 pH (5µg/ ml). No internalization of CDCP1 GFP was observed within 300 s of treatment with IgG7 pH .

Techniques: Confocal Microscopy, Software

Journal: Theranostics

Article Title: Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer

doi: 10.7150/thno.30736

Figure Lengend Snippet: CDCP1 is tyrosine phosphorylated during 10D7-induced internalization and degradation. ( A ) Lysates from HEY cells treated with 10D7 (5µg/ml) for the indicated times were examined by Western blot analysis for CDCP1, p-CDCP1-Y734, Src, p-Src-Y416, and GAPDH. Antibody dilution was 1:2,000 except the anti-GAPDH antibody which was 1:10,000. The graphs display CDCP1 and p-CDCP1-Y734 levels determined by densitometric analysis with data representing mean ± SEM from three independent experiments. ( B ) Anti-CDCP1 (1:2,000), -GFP (1:2,000) and -GAPDH (1:10,000) Western blot analysis of fractions collected by cell surface biotinylation of HEY cells expressing CDCP1 GFP , CDCP1 GFP -Y734F, -Y743F or -Y762F. ( C ) Analysis of semi-automated computer tracking of CDCP1 GFP and CDCP1 GFP -Y734F, -Y743F and -Y762F in response to 10D7. Left , representative image of CDCP1 GFP tracks that internalized in response to 10D7 pH in HEY cells. The image is an overlay onto cells of color-coded tracks (violet, tracks that moved the shortest distance; red, the tracks that moved the greatest distance). Right , Graph of distance moved over 5 min by CDCP1 GFP and CDCP1 GFP -Y734F, -Y743F and -Y762F in response to 10D7 (5 µg/ml). Data are median and range from the 100 tracks with the highest velocity in each experimental group from three independent experiments. ***P<0.001.

Techniques: Western Blot, Expressing

Journal: Theranostics

Article Title: Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer

doi: 10.7150/thno.30736

Figure Lengend Snippet: The Src inhibitor dasatinib blocks 10D7-induced phosphorylation and internalization of CDCP1. ( A ) HEY cells, treated for 2 h with dasatinib (200 nM), were incubated with 10D7 (5µg/ ml) for the indicated times. Lysates were examined by Western blot analysis for CDCP1 (1:2,000), pCDCP1-Y734 (1:2,000) and GAPDH (1:10,000). ( B ) Live-cell confocal microscopy images, acquired at the indicated time points after antibody treatment, of HEY-CDCP1 GFP cells pre-treated with dasatinib (200 nM), then incubated with 10D7 pH . Lower panels , 10D7 pH signal. Middle panels , CDCP1 GFP signal. Upper panels , overlay of 10D7 pH and CDCP1 GFP signals. ( C ) Graph of distance moved over 5 min by CDCP1 GFP in response to 10D7 in the presence and absence of dasatinib. Data are median and range from the 100 tracks with the highest velocity in each experimental group from three independent experiments. ***P<0.001.

Techniques: Incubation, Western Blot, Confocal Microscopy

Journal: Theranostics

Article Title: Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer

doi: 10.7150/thno.30736

Figure Lengend Snippet: PET-CT imaging of an EOC PDX. ( A ) Clear cell EOC PDX PH250. Left , hematoxylin and eosin stained section highlighting clear cell features at 40X with 10X magnification (inset). Right , Anti-CDCP1 immunohistochemistry (antibody 4115) highlighting strong CDCP1 expression by malignant cells with accentuation of signal on the plasma membrane at 40X and 10X magnification (inset). ( B ) Comparison of CDCP1 expression by HEY cells and PDX PH250 cells. Left , Anti-CDCP1 (antibody 4115; 1:2,000) and GAPDH (1:10,000) Western blot analysis of lysates from HEY cells, a HEY cell xenograft, and a PH250 PDX tumor. Right , Cell surface CDCP1 receptor number determined by flow cytometry of single cell suspensions of HEY cells and PDX PH250 cells. Receptor numbers per cell are indicated above the flow cytometry peaks. ( C ) Representative PET images of mice carrying subcutaneous PH250 PDX tumors on both flanks. 89 Zr-10D7 and 89 Zr-IgG1κ were injected intravenously three weeks after tumor cell inoculation, and imaging performed 144 h later. White arrowhead, tumor nodules. Yellow arrow, 89 Zr-IgG1κ signal accumulated in the spleen. ( D ) Quantitative bio-distribution analysis of 89 Zr-10D7 and 89 Zr-IgG1κ 144 h post injection (n = 4). 10D7 accumulates in tumors to a significantly higher degree than IgG1κ which accumulates in the spleen and liver. ***, P<0.001.

Techniques: Positron Emission Tomography-Computed Tomography, Imaging, Staining, Immunohistochemistry, Expressing, Western Blot, Flow Cytometry, Injection

Journal: Theranostics

Article Title: Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer

doi: 10.7150/thno.30736

Figure Lengend Snippet: 10D7-MMAE selectively inhibits colony formation of CDCP1 expressing but not non-expressing EOC cells. ( A ) Commassie stained gel of IgG and 10D7, and purified products from reactions of IgG and 10D7 with MMAE. ( B ) HEY cells were treated with 10D7-MMAE (5 µg/ml) for the indicated times and lysates examined by Western blot analysis for CDCP1, p-CDCP1-Y734, Src, p-Src-Y416 and GAPDH. Antibody dilution was 1:2,000 except the anti-GAPDH antibody which was 1:10,000. ( C ) Representative images of crystal violet stained colonies formed from HEY and OVMZ6-CDCP1 cells after treatment with the indicated concentrations of IgG, IgG-MMAE, 10D7 or 10D7-MMAE. ( D ) Graph of crystal violet staining, as a percentage of area (% Area), of colonies formed by HEY, OVMZ6-CDCP1 and OVMZ6 cells after treatment with increasing concentrations of IgG, IgG-MMAE, 10D7 or 10D7-MMAE. Data represent means ± SEM from three independent experiments. ***, P<0.001.

Techniques: Expressing, Staining, Purification, Western Blot